|
|
| Line 1: |
Line 1: |
| __NOTOC__
| | #REDIRECT [[Argatroban#Adult Indications and Dosage]] |
| {{Argatroban}}
| |
| {{CMG}}; {{AE}} {{JH}}
| |
| | |
| ==Dosage and Administration==
| |
| | |
| Each 50 mL glass vial contains 50 mg argatroban (1 mg/mL); and, as supplied, is ready for intravenous infusion. Dilution is not required.
| |
| | |
| Argatroban Injection is a clear, colorless to pale yellow solution. [[Parenteral]] drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit. Do not use if solution is cloudy, contains precipitates, or if the white flip top cap is not intact.
| |
| | |
| Vial may be inverted for use with a medical infusion set.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = ARGATROBAN INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595 | publisher = | date = | accessdate = }}</ref>
| |
| | |
| ==Reference==
| |
| | |
| {{reflist}}
| |
| | |
| {{FDA}}
| |
| | |
| [[Category:Cardiovascular Drugs]]
| |
| [[Category:Hematology]]
| |
| [[Category:Drugs]]
| |